4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001415889-25-017696
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2025-02-20 | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | D | ||
Loading xslF345X05/form4-06182025_040603.xml…